Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 0.81% is 125% above its 3-year average of 0.36%, near the low end of its 3-year range (0.03%–10.79%).
As of the fiscal period ended Tuesday, June 30, 2026. 16.04% above its 12-month average of 0.70%.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 0.81%.
DEBT TO ASSETS RATIO
0.81%
DEBT TO ASSETS RATIO AVG TTM
0.70%
DEBT TO ASSETS RATIO AVG 3Y
0.36%
DEBT TO ASSETS RATIO AVG 5Y
N/A
DEBT TO ASSETS RATIO AVG 10Y
N/A
DEBT TO ASSETS RATIO AVG 15Y
N/A
DEBT TO ASSETS RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+16.04%
CURRENT VS 3Y AVG
+125.12%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.10%
median of 663 covered companies
CURRENT VS SECTOR MEDIAN
+712.32%
vs the sector median at left
CG Oncology Inc.
Market Cap
$5.84B
Debt to Assets Ratio
0.81%
TTM Avg
0.70%
3Y Avg
0.36%
5Y Avg
N/A
Market Cap
$5.78B
Debt to Assets Ratio
0.01%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$5.90B
Debt to Assets Ratio
0.05%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$5.98B
Debt to Assets Ratio
0.52%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$5.52B
Debt to Assets Ratio
0.01%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$5.28B
Debt to Assets Ratio
0.30%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$5.25B
Debt to Assets Ratio
0.29%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| CG Oncology Inc. (CGON) | $5.84B | 0.81% | 0.70% | 0.36% | N/A |
| Kiniksa Pharmaceuticals International, plc (KNSA)vs › | $5.78B | 0.01% | N/A | N/A | N/A |
| Iovance Biotherapeutics, Inc. (IOVA)vs › | $5.90B | 0.05% | N/A | N/A | N/A |
| Ligand Pharmaceuticals Incorporated (LGND)vs › | $5.98B | 0.52% | N/A | N/A | N/A |
| GRAIL Inc. (GRAL)vs › | $6.02B | 0.03% | N/A | N/A | N/A |
| MiniMed Group, Inc. Common Stock (MMED)vs › | $5.52B | 0.01% | N/A | N/A | N/A |
| Doximity, Inc. (DOCS)vs › | $5.36B | 0.01% | N/A | N/A | N/A |
| CRISPR Therapeutics AG (CRSP)vs › | $5.28B | 0.30% | N/A | N/A | N/A |
| Cogent Biosciences, Inc. (COGT)vs › | $5.25B | 0.29% | N/A | N/A | N/A |
| Scholar Rock Holding Corporation (SRRK)vs › | $5.21B | 0.39% | N/A | N/A | N/A |
Debt/Assets
0.8%
Debt/Equity
0.01
Current Ratio
22.22
Interest Coverage
N/A
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 0.81% |
| 2026-03-31 | 0.67% |
| 2025-12-31 | 0.89% |
| 2025-09-30 | 0.99% |
| 2025-06-30 | 0.14% |
| 2025-03-31 | 0.14% |
| 2024-12-31 | 0.03% |
| 2024-09-30 | 0.05% |
| 2024-06-30 | 0.06% |
| 2024-03-31 | 0.07% |
| 2023-12-31 | 0.52% |
| 2023-09-30 | 0.24% |
| 2023-06-30 | 0.07% |
| 2022-12-31 | 10.79% |
